feed,title,long_url,short_url
MedRxiv,"A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste",https://medrxiv.org/cgi/content/short/2022.01.28.22270035v1?rss=1,https://bit.ly/3GgNV1D
MedRxiv,Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19,https://medrxiv.org/cgi/content/short/2022.01.28.22270043v1?rss=1,https://bit.ly/34nT7Dw
